

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.10417260 |
| 2 | cytidine metabolic process (GO:0046087) | 5.56480518 |
| 3 | cytidine catabolic process (GO:0006216) | 5.56480518 |
| 4 | cytidine deamination (GO:0009972) | 5.56480518 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.17733711 |
| 6 | protein neddylation (GO:0045116) | 5.17165324 |
| 7 | ATP synthesis coupled proton transport (GO:0015986) | 4.87686680 |
| 8 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.87686680 |
| 9 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.80343679 |
| 10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.38232734 |
| 11 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.12889933 |
| 12 | respiratory electron transport chain (GO:0022904) | 3.92140961 |
| 13 | electron transport chain (GO:0022900) | 3.88465495 |
| 14 | sequestering of actin monomers (GO:0042989) | 3.81165692 |
| 15 | platelet dense granule organization (GO:0060155) | 3.74728236 |
| 16 | otic vesicle formation (GO:0030916) | 3.62235830 |
| 17 | positive regulation of T cell apoptotic process (GO:0070234) | 3.61759067 |
| 18 | protein complex biogenesis (GO:0070271) | 3.46033794 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 3.39288264 |
| 20 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.34460752 |
| 21 | negative regulation of heart rate (GO:0010459) | 3.29027935 |
| 22 | autophagic vacuole fusion (GO:0000046) | 3.28471918 |
| 23 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.26015474 |
| 24 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.26015474 |
| 25 | eosinophil chemotaxis (GO:0048245) | 3.22947988 |
| 26 | regulation of chronic inflammatory response (GO:0002676) | 3.18471419 |
| 27 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.17976623 |
| 28 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.17976623 |
| 29 | NADH dehydrogenase complex assembly (GO:0010257) | 3.17976623 |
| 30 | regulation of regulatory T cell differentiation (GO:0045589) | 3.12674703 |
| 31 | actin nucleation (GO:0045010) | 3.12066242 |
| 32 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.11511809 |
| 33 | neutrophil activation involved in immune response (GO:0002283) | 3.06814709 |
| 34 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.05172857 |
| 35 | hydrogen ion transmembrane transport (GO:1902600) | 3.03120970 |
| 36 | ATP biosynthetic process (GO:0006754) | 3.02867585 |
| 37 | negative regulation of membrane potential (GO:0045837) | 3.00320656 |
| 38 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.98411009 |
| 39 | eosinophil migration (GO:0072677) | 2.90514089 |
| 40 | proton transport (GO:0015992) | 2.88207869 |
| 41 | positive regulation of prostaglandin secretion (GO:0032308) | 2.88026063 |
| 42 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.87889987 |
| 43 | hydrogen transport (GO:0006818) | 2.82347380 |
| 44 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.82280725 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.76705745 |
| 46 | neutrophil activation (GO:0042119) | 2.74599585 |
| 47 | negative regulation of T cell apoptotic process (GO:0070233) | 2.73818894 |
| 48 | organelle membrane fusion (GO:0090174) | 2.69106441 |
| 49 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.64291779 |
| 50 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.64248277 |
| 51 | chaperone-mediated protein transport (GO:0072321) | 2.64120763 |
| 52 | behavioral response to nicotine (GO:0035095) | 2.63837104 |
| 53 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.62788657 |
| 54 | response to pheromone (GO:0019236) | 2.62097468 |
| 55 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.60423819 |
| 56 | granulocyte activation (GO:0036230) | 2.60394071 |
| 57 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.56885595 |
| 58 | B cell mediated immunity (GO:0019724) | 2.56240760 |
| 59 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.55743361 |
| 60 | regulation of T cell apoptotic process (GO:0070232) | 2.55393832 |
| 61 | ribosomal small subunit assembly (GO:0000028) | 2.54840742 |
| 62 | T cell costimulation (GO:0031295) | 2.49180587 |
| 63 | lymphocyte costimulation (GO:0031294) | 2.47387714 |
| 64 | response to interferon-beta (GO:0035456) | 2.46007693 |
| 65 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.45959337 |
| 66 | GPI anchor metabolic process (GO:0006505) | 2.45709407 |
| 67 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.45351883 |
| 68 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.44720891 |
| 69 | proteasome assembly (GO:0043248) | 2.42711391 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 2.41986540 |
| 71 | amine catabolic process (GO:0009310) | 2.41986540 |
| 72 | positive regulation of mast cell activation (GO:0033005) | 2.41927331 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 2.40185514 |
| 74 | regulation of activation of Janus kinase activity (GO:0010533) | 2.39042918 |
| 75 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.38984178 |
| 76 | GPI anchor biosynthetic process (GO:0006506) | 2.38046985 |
| 77 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.37323006 |
| 78 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.36353000 |
| 79 | regulation of interleukin-8 secretion (GO:2000482) | 2.35141474 |
| 80 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.34697602 |
| 81 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.33596814 |
| 82 | positive regulation of defense response to virus by host (GO:0002230) | 2.33030112 |
| 83 | positive regulation of fatty acid transport (GO:2000193) | 2.31530629 |
| 84 | cytochrome complex assembly (GO:0017004) | 2.30938834 |
| 85 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.30732508 |
| 86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.30338641 |
| 87 | positive regulation of mast cell degranulation (GO:0043306) | 2.30338641 |
| 88 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.30156794 |
| 89 | protein-cofactor linkage (GO:0018065) | 2.30154175 |
| 90 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.30050989 |
| 91 | positive regulation of antigen processing and presentation (GO:0002579) | 2.29931245 |
| 92 | limb bud formation (GO:0060174) | 2.28868186 |
| 93 | adaptation of signaling pathway (GO:0023058) | 2.28635534 |
| 94 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.28509853 |
| 95 | negative regulation by host of viral transcription (GO:0043922) | 2.27796065 |
| 96 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.27243155 |
| 97 | sulfation (GO:0051923) | 2.26550002 |
| 98 | maturation of SSU-rRNA (GO:0030490) | 2.25476832 |
| 99 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.25351468 |
| 100 | S-adenosylmethionine metabolic process (GO:0046500) | 2.24456105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.03432758 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.95274134 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.77870017 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.47522737 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.38676737 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.99502718 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.96997900 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.66236618 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.45058681 |
| 10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26391276 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.94643276 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.94591102 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.94419327 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.84183507 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.81035236 |
| 16 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.73838831 |
| 17 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.67827001 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.66054550 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64433058 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.62488750 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.62141481 |
| 22 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.58309215 |
| 23 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.57484662 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57250680 |
| 25 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.53946695 |
| 26 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.52216660 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51554602 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49926508 |
| 29 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.49691628 |
| 30 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.46827385 |
| 31 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.45656911 |
| 32 | AR_20517297_ChIP-Seq_VCAP_Human | 1.44716199 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.44114738 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.42800728 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42599783 |
| 36 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.42437683 |
| 37 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.42249244 |
| 38 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.41777770 |
| 39 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.41194425 |
| 40 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.39778608 |
| 41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39089549 |
| 42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.39008492 |
| 43 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.33803208 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30591083 |
| 45 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.30249370 |
| 46 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23437932 |
| 47 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23437932 |
| 48 | MYB_26560356_Chip-Seq_TH2_Human | 1.22949080 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20848237 |
| 50 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.19908780 |
| 51 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.19877009 |
| 52 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.19804074 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19489969 |
| 54 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.19384835 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19356240 |
| 56 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.19037043 |
| 57 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.18942549 |
| 58 | NCOR_22424771_ChIP-Seq_293T_Human | 1.18677414 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.17333384 |
| 60 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.15526640 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15254463 |
| 62 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.14641921 |
| 63 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.14641921 |
| 64 | P300_27268052_Chip-Seq_Bcells_Human | 1.10664731 |
| 65 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.09085324 |
| 66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.08944257 |
| 67 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.06967658 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06648447 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04537602 |
| 70 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.04488079 |
| 71 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04274575 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03060303 |
| 73 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.02073967 |
| 74 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.01001918 |
| 75 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.99979311 |
| 76 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.99774483 |
| 77 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98778600 |
| 78 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.98185857 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97353300 |
| 80 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96527377 |
| 81 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96480781 |
| 82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96137107 |
| 83 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95687162 |
| 84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95551666 |
| 85 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95328547 |
| 86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94685190 |
| 87 | ERA_21632823_ChIP-Seq_H3396_Human | 0.94455861 |
| 88 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93448430 |
| 89 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92638481 |
| 90 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.92242074 |
| 91 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.92027679 |
| 92 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91781493 |
| 93 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.90678615 |
| 94 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.90251923 |
| 95 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89841504 |
| 96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88999781 |
| 97 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.88077713 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88051460 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86854183 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.86043774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.87217210 |
| 2 | MP0000566_synostosis | 3.46908210 |
| 3 | MP0004147_increased_porphyrin_level | 3.03902464 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.74703921 |
| 5 | MP0003724_increased_susceptibility_to | 2.70482426 |
| 6 | MP0003646_muscle_fatigue | 2.62550917 |
| 7 | MP0009785_altered_susceptibility_to | 2.54889374 |
| 8 | MP0003136_yellow_coat_color | 2.51297838 |
| 9 | MP0005670_abnormal_white_adipose | 2.47991944 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.45859818 |
| 11 | MP0005360_urolithiasis | 2.44229925 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.34733699 |
| 13 | MP0009764_decreased_sensitivity_to | 2.20065744 |
| 14 | MP0005000_abnormal_immune_tolerance | 1.96714036 |
| 15 | MP0005646_abnormal_pituitary_gland | 1.83699049 |
| 16 | MP0002653_abnormal_ependyma_morphology | 1.76928911 |
| 17 | MP0004142_abnormal_muscle_tone | 1.76928576 |
| 18 | MP0010155_abnormal_intestine_physiology | 1.71728995 |
| 19 | MP0009379_abnormal_foot_pigmentation | 1.69501334 |
| 20 | MP0001800_abnormal_humoral_immune | 1.67892411 |
| 21 | MP0003436_decreased_susceptibility_to | 1.67724065 |
| 22 | MP0002736_abnormal_nociception_after | 1.66980168 |
| 23 | MP0005025_abnormal_response_to | 1.65204495 |
| 24 | MP0002723_abnormal_immune_serum | 1.63204766 |
| 25 | MP0008872_abnormal_physiological_respon | 1.61133038 |
| 26 | MP0002102_abnormal_ear_morphology | 1.55243761 |
| 27 | MP0004885_abnormal_endolymph | 1.53338009 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 1.53153952 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.51831677 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.51228535 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.50619605 |
| 32 | MP0000685_abnormal_immune_system | 1.50172630 |
| 33 | MP0000343_altered_response_to | 1.47868226 |
| 34 | MP0005377_hearing/vestibular/ear_phenot | 1.47552250 |
| 35 | MP0003878_abnormal_ear_physiology | 1.47552250 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.42955861 |
| 37 | MP0003011_delayed_dark_adaptation | 1.41906951 |
| 38 | MP0001819_abnormal_immune_cell | 1.40498069 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.39952098 |
| 40 | MP0005387_immune_system_phenotype | 1.37866114 |
| 41 | MP0001790_abnormal_immune_system | 1.37866114 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.35608279 |
| 43 | MP0005083_abnormal_biliary_tract | 1.31838273 |
| 44 | MP0002095_abnormal_skin_pigmentation | 1.26819946 |
| 45 | MP0001919_abnormal_reproductive_system | 1.26293503 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.24927791 |
| 47 | MP0003866_abnormal_defecation | 1.21535135 |
| 48 | MP0003186_abnormal_redox_activity | 1.19243020 |
| 49 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18988698 |
| 50 | MP0006292_abnormal_olfactory_placode | 1.18964703 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 1.17146019 |
| 52 | MP0008004_abnormal_stomach_pH | 1.16713988 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.15572329 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.14850109 |
| 55 | MP0009765_abnormal_xenobiotic_induced | 1.10082479 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.09632762 |
| 57 | MP0005410_abnormal_fertilization | 1.09590840 |
| 58 | MP0002419_abnormal_innate_immunity | 1.09376295 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.07243268 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.07179191 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 1.06911196 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.06379419 |
| 63 | MP0001905_abnormal_dopamine_level | 1.05530527 |
| 64 | MP0000716_abnormal_immune_system | 1.00528692 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 0.98982170 |
| 66 | MP0009763_increased_sensitivity_to | 0.98624114 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 0.96609428 |
| 68 | MP0006082_CNS_inflammation | 0.96115182 |
| 69 | MP0001663_abnormal_digestive_system | 0.96109756 |
| 70 | MP0006276_abnormal_autonomic_nervous | 0.94481840 |
| 71 | MP0001970_abnormal_pain_threshold | 0.94471647 |
| 72 | MP0003879_abnormal_hair_cell | 0.94114565 |
| 73 | MP0008469_abnormal_protein_level | 0.91987501 |
| 74 | MP0001485_abnormal_pinna_reflex | 0.91557981 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.91168701 |
| 76 | MP0000230_abnormal_systemic_arterial | 0.90745976 |
| 77 | MP0002398_abnormal_bone_marrow | 0.89124771 |
| 78 | MP0001764_abnormal_homeostasis | 0.88226010 |
| 79 | MP0001666_abnormal_nutrient_absorption | 0.88130818 |
| 80 | MP0000631_abnormal_neuroendocrine_gland | 0.87133291 |
| 81 | MP0002733_abnormal_thermal_nociception | 0.86747361 |
| 82 | MP0000681_abnormal_thyroid_gland | 0.84497678 |
| 83 | MP0005332_abnormal_amino_acid | 0.84219155 |
| 84 | MP0005085_abnormal_gallbladder_physiolo | 0.83400538 |
| 85 | MP0008995_early_reproductive_senescence | 0.81794874 |
| 86 | MP0002282_abnormal_trachea_morphology | 0.81607168 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.81213958 |
| 88 | MP0003195_calcinosis | 0.78737757 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.78645741 |
| 90 | MP0005166_decreased_susceptibility_to | 0.78229417 |
| 91 | MP0002429_abnormal_blood_cell | 0.77378486 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.77083022 |
| 93 | MP0001873_stomach_inflammation | 0.75513177 |
| 94 | MP0000689_abnormal_spleen_morphology | 0.74988159 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.74438903 |
| 96 | MP0005389_reproductive_system_phenotype | 0.73559325 |
| 97 | MP0003075_altered_response_to | 0.73289612 |
| 98 | MP0002272_abnormal_nervous_system | 0.73095794 |
| 99 | MP0008877_abnormal_DNA_methylation | 0.69288464 |
| 100 | MP0004947_skin_inflammation | 0.69150059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.49410913 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.16155849 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.13122486 |
| 4 | Progressive macrocephaly (HP:0004481) | 3.80523116 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.79406710 |
| 6 | Acute encephalopathy (HP:0006846) | 3.79210614 |
| 7 | Hepatocellular necrosis (HP:0001404) | 3.61775338 |
| 8 | Increased CSF lactate (HP:0002490) | 3.51063690 |
| 9 | Partial duplication of thumb phalanx (HP:0009944) | 3.44518546 |
| 10 | Hepatic necrosis (HP:0002605) | 3.38038830 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.18133760 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.18133760 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.14983633 |
| 14 | 3-Methylglutaconic aciduria (HP:0003535) | 3.12049911 |
| 15 | Generalized aminoaciduria (HP:0002909) | 3.05795589 |
| 16 | Cerebral edema (HP:0002181) | 3.00966059 |
| 17 | Increased intramyocellular lipid droplets (HP:0012240) | 3.00400222 |
| 18 | Partial duplication of the phalanx of hand (HP:0009999) | 2.96988036 |
| 19 | IgG deficiency (HP:0004315) | 2.92457099 |
| 20 | Stenosis of the external auditory canal (HP:0000402) | 2.88211765 |
| 21 | Conical tooth (HP:0000698) | 2.80499571 |
| 22 | Nausea (HP:0002018) | 2.77887005 |
| 23 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.75957017 |
| 24 | Increased hepatocellular lipid droplets (HP:0006565) | 2.72534670 |
| 25 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.65562820 |
| 26 | Congenital stationary night blindness (HP:0007642) | 2.62126605 |
| 27 | Increased muscle lipid content (HP:0009058) | 2.61240343 |
| 28 | Chronic otitis media (HP:0000389) | 2.58130553 |
| 29 | Increased serum lactate (HP:0002151) | 2.52503667 |
| 30 | Lipid accumulation in hepatocytes (HP:0006561) | 2.51256709 |
| 31 | Lactic acidosis (HP:0003128) | 2.49829576 |
| 32 | Stomatitis (HP:0010280) | 2.47490853 |
| 33 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.46878801 |
| 34 | Increased IgM level (HP:0003496) | 2.46806775 |
| 35 | Abnormality of magnesium homeostasis (HP:0004921) | 2.45394898 |
| 36 | Abnormality of alanine metabolism (HP:0010916) | 2.44595687 |
| 37 | Hyperalaninemia (HP:0003348) | 2.44595687 |
| 38 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.44595687 |
| 39 | Aplastic anemia (HP:0001915) | 2.43565613 |
| 40 | Glycosuria (HP:0003076) | 2.42540415 |
| 41 | Abnormality of urine glucose concentration (HP:0011016) | 2.42540415 |
| 42 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.39907411 |
| 43 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.38925396 |
| 44 | Stomach cancer (HP:0012126) | 2.37875631 |
| 45 | Exertional dyspnea (HP:0002875) | 2.37436574 |
| 46 | Type II lissencephaly (HP:0007260) | 2.33812909 |
| 47 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.32987533 |
| 48 | Optic disc pallor (HP:0000543) | 2.32606196 |
| 49 | Decreased central vision (HP:0007663) | 2.29831759 |
| 50 | True hermaphroditism (HP:0010459) | 2.29404011 |
| 51 | Megalencephaly (HP:0001355) | 2.25242822 |
| 52 | Petechiae (HP:0000967) | 2.24243661 |
| 53 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.21813433 |
| 54 | Recurrent corneal erosions (HP:0000495) | 2.20320608 |
| 55 | Abnormality of the costochondral junction (HP:0000919) | 2.19708463 |
| 56 | Aplasia involving bones of the extremities (HP:0009825) | 2.19087593 |
| 57 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.19087593 |
| 58 | Aplasia of the phalanges of the hand (HP:0009802) | 2.19087593 |
| 59 | Lethargy (HP:0001254) | 2.13288465 |
| 60 | Abnormality of the prostate (HP:0008775) | 2.05039772 |
| 61 | Congenital, generalized hypertrichosis (HP:0004540) | 2.02952081 |
| 62 | Abnormality of renal resorption (HP:0011038) | 2.02925065 |
| 63 | Hypomagnesemia (HP:0002917) | 2.01885541 |
| 64 | Humeroradial synostosis (HP:0003041) | 2.00736788 |
| 65 | Synostosis involving the elbow (HP:0003938) | 2.00736788 |
| 66 | Obstructive lung disease (HP:0006536) | 2.00476916 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00476916 |
| 68 | Respiratory failure (HP:0002878) | 1.98814938 |
| 69 | Abnormal hemoglobin (HP:0011902) | 1.97871039 |
| 70 | Retinal dysplasia (HP:0007973) | 1.95016537 |
| 71 | Hypoplasia of the ulna (HP:0003022) | 1.94696948 |
| 72 | Abolished electroretinogram (ERG) (HP:0000550) | 1.94643711 |
| 73 | Pancreatitis (HP:0001733) | 1.93124579 |
| 74 | Abnormality of the labia minora (HP:0012880) | 1.88974594 |
| 75 | Myositis (HP:0100614) | 1.86370250 |
| 76 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.85839241 |
| 77 | Pancreatic cysts (HP:0001737) | 1.85181937 |
| 78 | Hypoproteinemia (HP:0003075) | 1.85167345 |
| 79 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.85078397 |
| 80 | Type 2 muscle fiber atrophy (HP:0003554) | 1.85031428 |
| 81 | Abnormality of midbrain morphology (HP:0002418) | 1.84440733 |
| 82 | Molar tooth sign on MRI (HP:0002419) | 1.84440733 |
| 83 | Congenital sensorineural hearing impairment (HP:0008527) | 1.80872957 |
| 84 | Optic neuritis (HP:0100653) | 1.80728458 |
| 85 | Retrobulbar optic neuritis (HP:0100654) | 1.80728458 |
| 86 | Exercise intolerance (HP:0003546) | 1.80593976 |
| 87 | Hyperphosphaturia (HP:0003109) | 1.79973302 |
| 88 | Leukodystrophy (HP:0002415) | 1.76942187 |
| 89 | Abnormality of the 2nd finger (HP:0004100) | 1.76289181 |
| 90 | Absent septum pellucidum (HP:0001331) | 1.75397694 |
| 91 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.75390129 |
| 92 | Respiratory distress (HP:0002098) | 1.73423476 |
| 93 | Hyperglycinemia (HP:0002154) | 1.70533983 |
| 94 | Encephalitis (HP:0002383) | 1.69996580 |
| 95 | Purpura (HP:0000979) | 1.69947665 |
| 96 | Attenuation of retinal blood vessels (HP:0007843) | 1.67395610 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.66205970 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 1.66205970 |
| 99 | Duplication of thumb phalanx (HP:0009942) | 1.66083711 |
| 100 | Methylmalonic aciduria (HP:0012120) | 1.65764978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.32283167 |
| 2 | TESK2 | 3.29992589 |
| 3 | TLK1 | 2.99337439 |
| 4 | PINK1 | 2.98813040 |
| 5 | KDR | 2.82314181 |
| 6 | BCKDK | 2.79316778 |
| 7 | MAP4K2 | 2.59062010 |
| 8 | TAOK3 | 2.48517350 |
| 9 | ADRBK2 | 2.34473409 |
| 10 | FGFR2 | 2.13834962 |
| 11 | CDK19 | 2.07466816 |
| 12 | GRK6 | 1.96815444 |
| 13 | STK16 | 1.85276972 |
| 14 | ZAK | 1.82589889 |
| 15 | GRK1 | 1.79525748 |
| 16 | NUAK1 | 1.73960465 |
| 17 | MAP4K1 | 1.66614255 |
| 18 | IKBKB | 1.63726309 |
| 19 | BMPR2 | 1.62859651 |
| 20 | MAPKAPK3 | 1.61009465 |
| 21 | MST4 | 1.54848117 |
| 22 | TEC | 1.48820854 |
| 23 | SYK | 1.45621883 |
| 24 | MYLK | 1.36475667 |
| 25 | LIMK1 | 1.36330918 |
| 26 | PIM2 | 1.29287370 |
| 27 | MAP3K11 | 1.28423752 |
| 28 | WNK4 | 1.21418021 |
| 29 | ITK | 1.19940150 |
| 30 | TIE1 | 1.18654426 |
| 31 | ACVR1B | 1.16529466 |
| 32 | BTK | 1.13291476 |
| 33 | MAP2K7 | 1.09965965 |
| 34 | FRK | 1.01441030 |
| 35 | NME1 | 1.00197621 |
| 36 | ZAP70 | 0.99356698 |
| 37 | LYN | 0.98616003 |
| 38 | RIPK4 | 0.97659462 |
| 39 | BLK | 0.97363370 |
| 40 | ADRBK1 | 0.95212026 |
| 41 | GRK7 | 0.94398326 |
| 42 | DYRK2 | 0.93959179 |
| 43 | MAP3K12 | 0.93835316 |
| 44 | FES | 0.93675835 |
| 45 | IKBKE | 0.87799289 |
| 46 | OXSR1 | 0.86345127 |
| 47 | MATK | 0.85031733 |
| 48 | KIT | 0.84842099 |
| 49 | BMPR1B | 0.83514683 |
| 50 | EPHB2 | 0.82877176 |
| 51 | JAK3 | 0.82779772 |
| 52 | ABL2 | 0.80821245 |
| 53 | PRKCQ | 0.80713370 |
| 54 | LCK | 0.78396529 |
| 55 | PHKG1 | 0.77639565 |
| 56 | PHKG2 | 0.77639565 |
| 57 | CSK | 0.74737394 |
| 58 | CSF1R | 0.74632240 |
| 59 | MUSK | 0.72505230 |
| 60 | OBSCN | 0.71303586 |
| 61 | PIM1 | 0.69421612 |
| 62 | MAP2K6 | 0.68434254 |
| 63 | RPS6KA5 | 0.68390473 |
| 64 | MINK1 | 0.66974921 |
| 65 | TNK2 | 0.66883192 |
| 66 | NME2 | 0.64406938 |
| 67 | PDK2 | 0.62895012 |
| 68 | ARAF | 0.62483310 |
| 69 | CSNK1G3 | 0.62460007 |
| 70 | PIK3CA | 0.62023552 |
| 71 | ILK | 0.61807329 |
| 72 | INSRR | 0.61407381 |
| 73 | PAK1 | 0.59594575 |
| 74 | CHUK | 0.56789955 |
| 75 | WNK3 | 0.55831312 |
| 76 | TBK1 | 0.55526708 |
| 77 | DYRK1B | 0.55251882 |
| 78 | MAP3K5 | 0.53440670 |
| 79 | PRKACA | 0.52461920 |
| 80 | ROCK1 | 0.51118988 |
| 81 | MAP3K6 | 0.49038973 |
| 82 | CSNK1G2 | 0.47702982 |
| 83 | VRK2 | 0.47560794 |
| 84 | DAPK2 | 0.46928459 |
| 85 | EIF2AK1 | 0.46106777 |
| 86 | MAPK13 | 0.44897667 |
| 87 | DAPK1 | 0.44473727 |
| 88 | IGF1R | 0.44049120 |
| 89 | PRKCA | 0.43614735 |
| 90 | TRIM28 | 0.42459559 |
| 91 | VRK1 | 0.42389836 |
| 92 | GRK5 | 0.42303429 |
| 93 | MARK3 | 0.40338995 |
| 94 | AKT3 | 0.40240908 |
| 95 | IRAK4 | 0.38065697 |
| 96 | PRKACG | 0.35840995 |
| 97 | CAMK2A | 0.35712633 |
| 98 | ABL1 | 0.34962551 |
| 99 | PRKCD | 0.34875861 |
| 100 | CSNK1A1L | 0.33072996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.91462661 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.80440343 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.20661364 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.17505506 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.13943238 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.07118199 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.82589684 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.70653325 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.66450435 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.37137191 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.17797888 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.11011508 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.09322268 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.99354399 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93775200 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.88165148 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77635190 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.74080205 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73416654 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.72965191 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65203223 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.62610784 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.62200832 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61820488 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57029319 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.56268276 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.45817180 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.41829422 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.40917374 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34862183 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.29006327 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28145940 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.13864228 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13845917 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.07701812 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.03362605 |
| 37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00304448 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98589692 |
| 39 | Malaria_Homo sapiens_hsa05144 | 0.98450976 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98273149 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92282531 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.92166756 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89798296 |
| 44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86030383 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.86024510 |
| 46 | Mineral absorption_Homo sapiens_hsa04978 | 0.83259553 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81506844 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79237743 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76993528 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76959701 |
| 51 | Protein export_Homo sapiens_hsa03060 | 0.75644620 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74617140 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74014940 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 0.72207817 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.71438258 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66598681 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65306913 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64696136 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63111914 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.61935848 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60541757 |
| 62 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.60228977 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59965128 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.58897659 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58038309 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54763955 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53946739 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53342370 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.52842911 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52575118 |
| 71 | Morphine addiction_Homo sapiens_hsa05032 | 0.52299939 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50411325 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49914766 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.49206846 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46120518 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45652756 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45455710 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.43248208 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40885263 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.40747791 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40593961 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40313768 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36543261 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36470068 |
| 85 | GABAergic synapse_Homo sapiens_hsa04727 | 0.33219178 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.31101242 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30267472 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.29552036 |
| 89 | Nicotine addiction_Homo sapiens_hsa05033 | 0.29498951 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.28711271 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.28285325 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25601533 |
| 93 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24774714 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.24201290 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21976449 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21901058 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21808004 |
| 98 | Homologous recombination_Homo sapiens_hsa03440 | 0.20003487 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.19394143 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.19111816 |

